Thomas K. Fehring, MD, Publishes Results of OREF-Funded Study in JBJS
Results of a multicenter randomized trial comparing one- and two-stage treatment for periprosthetic joint infection show promise.
8-29-26 | Updated: 11-20-2026
In 2015, Thomas K. Fehring, MD, received an OREF Clinical Research Grant in Hip and Knee Arthroplasty Infection to conduct a prospective, multicenter randomized trial comparing the results of one- and two-stage treatment for periprosthetic joint infection (PJI). A summary of the research Dr. Fehring conducted with the funding is available on the OREF website.
Results, published in the July 2026 issue of The Journal of Bone and Joint Surgery are promising, showing that when study protocols are followed, one-stage treatment for PJI is not inferior to two-stage treatment. Read the JBJS article.
